These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29352435)

  • 1. Outcome of hip and knee periprosthetic joint infections caused by pathogens resistant to biofilm-active antibiotics: results from a prospective cohort study.
    Akgün D; Perka C; Trampuz A; Renz N
    Arch Orthop Trauma Surg; 2018 May; 138(5):635-642. PubMed ID: 29352435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of short versus long interval in two-stage exchange for periprosthetic joint infection: a prospective cohort study.
    Winkler T; Stuhlert MGW; Lieb E; Müller M; von Roth P; Preininger B; Trampuz A; Perka CF
    Arch Orthop Trauma Surg; 2019 Mar; 139(3):295-303. PubMed ID: 30443674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early prosthetic hip joint infection treated with debridement, prosthesis retention and biofilm-active antibiotics: functional outcomes, quality of life and complications.
    Aboltins C; Dowsey MM; Peel T; Lim WK; Parikh S; Stanley P; Choong PF
    Intern Med J; 2013 Jul; 43(7):810-5. PubMed ID: 23656615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biofilm-active antibiotic treatment improves the outcome of knee periprosthetic joint infection: Results from a 6-year prospective cohort study.
    Gellert M; Hardt S; Köder K; Renz N; Perka C; Trampuz A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105904. PubMed ID: 31958506
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enterococcal periprosthetic joint infection: clinical and microbiological findings from an 8-year retrospective cohort study.
    Renz N; Trebse R; Akgün D; Perka C; Trampuz A
    BMC Infect Dis; 2019 Dec; 19(1):1083. PubMed ID: 31881851
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Difficult-to-treat pathogens significantly reduce infection resolution in periprosthetic joint infections.
    Wimmer MD; Hischebeth GTR; Randau TM; Gathen M; Schildberg FA; Fröschen FS; Kohlhof H; Gravius S
    Diagn Microbiol Infect Dis; 2020 Oct; 98(2):115114. PubMed ID: 32712505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Periprosthetic Infection Recurrence After 2-Stage Exchange Arthroplasty: Failure or Fate?
    Triantafyllopoulos GK; Memtsoudis SG; Zhang W; Ma Y; Sculco TP; Poultsides LA
    J Arthroplasty; 2017 Feb; 32(2):526-531. PubMed ID: 27646832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Standard Versus Extended Culture Duration in Acute Hip and Knee Periprosthetic Joint Infection.
    Klement MR; Cunningham DJ; Wooster BM; Wellman SS; Bolognesi MP; Green CL; Garrigues GE
    J Am Acad Orthop Surg; 2019 May; 27(9):e437-e443. PubMed ID: 30431505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Outcome of Massive Endoprostheses Used for Managing Periprosthetic Joint Infections of the Hip and Knee.
    Alvand A; Grammatopoulos G; de Vos F; Scarborough M; Kendrick B; Price A; Gundle R; Whitwell D; Jackson W; Taylor A; Gibbons CLMH
    J Arthroplasty; 2018 Mar; 33(3):829-834. PubMed ID: 29107499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High failure rates in treatment of streptococcal periprosthetic joint infection: results from a seven-year retrospective cohort study.
    Akgün D; Trampuz A; Perka C; Renz N
    Bone Joint J; 2017 May; 99-B(5):653-659. PubMed ID: 28455475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Therapy, Microbiological Findings, and Comorbidity Influence the Outcome of Prosthetic Joint Infections Undergoing 2-Stage Exchange.
    Ascione T; Pagliano P; Balato G; Mariconda M; Rotondo R; Esposito S
    J Arthroplasty; 2017 Jul; 32(7):2239-2243. PubMed ID: 28372916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the microbial pattern of periprosthetic joint infections of the hip and knee.
    Rosteius T; Jansen O; Fehmer T; Baecker H; Citak M; Schildhauer TA; Geßmann J
    J Med Microbiol; 2018 Nov; 67(11):1608-1613. PubMed ID: 30207518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic Suppression of Periprosthetic Joint Infections with Oral Antibiotics Increases Infection-Free Survivorship.
    Siqueira MB; Saleh A; Klika AK; O'Rourke C; Schmitt S; Higuera CA; Barsoum WK
    J Bone Joint Surg Am; 2015 Aug; 97(15):1220-32. PubMed ID: 26246256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High cure rate of periprosthetic hip joint infection with multidisciplinary team approach using standardized two-stage exchange.
    Akgün D; Müller M; Perka C; Winkler T
    J Orthop Surg Res; 2019 Mar; 14(1):78. PubMed ID: 30866970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Periprosthetic Joint Infections Caused by Enterococci Have Poor Outcomes.
    Kheir MM; Tan TL; Higuera C; George J; Della Valle CJ; Shen M; Parvizi J
    J Arthroplasty; 2017 Mar; 32(3):933-947. PubMed ID: 27789094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Alpha-defensin Test for Periprosthetic Joint Infections Is Not Affected by Prior Antibiotic Administration.
    Shahi A; Parvizi J; Kazarian GS; Higuera C; Frangiamore S; Bingham J; Beauchamp C; Valle CD; Deirmengian C
    Clin Orthop Relat Res; 2016 Jul; 474(7):1610-5. PubMed ID: 26864855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Preoperative Antimicrobial Prophylaxis Influence the Diagnostic Potential of Periprosthetic Tissues in Hip or Knee Infections?
    Bedenčič K; Kavčič M; Faganeli N; Mihalič R; Mavčič B; Dolenc J; Bajc Z; Trebše R
    Clin Orthop Relat Res; 2016 Jan; 474(1):258-64. PubMed ID: 26253269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synovial Cytokines and the MSIS Criteria Are Not Useful for Determining Infection Resolution After Periprosthetic Joint Infection Explantation.
    Frangiamore SJ; Siqueira MB; Saleh A; Daly T; Higuera CA; Barsoum WK
    Clin Orthop Relat Res; 2016 Jul; 474(7):1630-9. PubMed ID: 26821163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difficult to treat: are there organism-dependent differences and overall risk factors in success rates for two-stage knee revision?
    Faschingbauer M; Bieger R; Kappe T; Weiner C; Freitag T; Reichel H
    Arch Orthop Trauma Surg; 2020 Nov; 140(11):1595-1602. PubMed ID: 31960169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perioperative Timing of Infliximab and the Risk of Serious Infection After Elective Hip and Knee Arthroplasty.
    George MD; Baker JF; Hsu JY; Wu Q; Xie F; Chen L; Yun H; Curtis JR
    Arthritis Care Res (Hoboken); 2017 Dec; 69(12):1845-1854. PubMed ID: 28129484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.